By being vertically integrated and owning all steps of the pharmaceutical development and production process, Accord can bring high quality medicines to patients faster, more economically and with greater efficiency.
Accord has one of the most dynamic product pipelines in the pharmaceutical industry. We already have a portfolio of over 120 molecules across multiple therapeutic classes. We are committed to build up this number to compete with the largest product ranges in the sector.
Accord has a particular focus on ensuring the safe use of our products, both for patients and medical professionals.
Accord's portfolio comprises a multitude of different pharmaceutical forms, including; tablets (standard, film- coated, effervescent, sustained release, cytotoxic and immunosuppressant), capsules, cytotoxic injectables (powders and solution vials), non- cytotoxic (ampoules) and INCB controlled drugs.
South African Marketing Authorisations